Related Experiment Video
Updated: May 19, 2026
05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Sentinel lymph node mapping in early breast cancer - Our experience
Indian Journal of Surgical Oncology
|August 30, 2012
Summary
Sentinel lymph node biopsy is a safe and effective method for staging breast cancer axillary lymph nodes. This technique offers reduced morbidity compared to traditional axillary lymph node dissection.
Area of Science:
- Oncology
- Surgical Pathology
- Breast Cancer Research
Background:
- Axillary lymph node status is critical for breast cancer prognosis.
- Sentinel lymph node (SLN) biopsy offers a less morbid alternative to axillary clearance with comparable efficacy.
Purpose of the Study:
- To evaluate the efficacy and safety of sentinel lymph node biopsy in early breast cancer patients.
- To compare the identification rates of combined technique versus blue dye alone for SLN biopsy.
Main Methods:
- A study of 523 early breast cancer patients from May 1996 to September 2009.
- Patients underwent SLN biopsy using either a combined technique or blue dye alone.
- All patients subsequently underwent axillary lymph node dissection (ALND) regardless of SLN status.
Main Results:
- The overall SLN identification rate was 91.3% (478/523).
- The combined technique showed a higher identification rate (94.3%) than blue dye alone (87.8%).
- SLN biopsy demonstrated high sensitivity (91.5%), negative predictive value (96.14%), and accuracy (97.2%).
Conclusions:
- Sentinel lymph node mapping is a safe and simple technique for assessing axillary lymph node involvement.
- SLN biopsy is associated with reduced arm edema and shoulder morbidity compared to ALND.
- Long-term data on tumor recurrence and survival following SLN biopsy are still pending.
